These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 18586317)

  • 1. Systemic and local responses in aspirin-exacerbated respiratory disease: same or different disease?
    González-Pérez R; Poza-Guedes P; Vives-Conesa R
    J Allergy Clin Immunol; 2008 Aug; 122(2):430-1. PubMed ID: 18586317
    [No Abstract]   [Full Text] [Related]  

  • 2. The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease.
    White AA; Stevenson DD; Simon RA
    Ann Allergy Asthma Immunol; 2005 Oct; 95(4):330-5. PubMed ID: 16279562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin-exacerbated respiratory disease: clinical disease and diagnosis.
    Bochenek G; Niżankowska-Mogilnicka E
    Immunol Allergy Clin North Am; 2013 May; 33(2):147-61. PubMed ID: 23639705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal ketorolac challenge for the diagnosis of aspirin-exacerbated respiratory disease.
    White A; Bigby T; Stevenson D
    Ann Allergy Asthma Immunol; 2006 Aug; 97(2):190-5. PubMed ID: 16937750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value of the oral provocation test with aspirin in the diagnosis of Fernand-Widal syndrome. Apropos of 33 cases].
    Serrano E; Didier A; Vincent P; Laval F; Leophonte P; Pessey JJ
    Rev Laryngol Otol Rhinol (Bord); 1987; 108(3):201-4. PubMed ID: 3616207
    [No Abstract]   [Full Text] [Related]  

  • 6. EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity.
    Nizankowska-Mogilnicka E; Bochenek G; Mastalerz L; Swierczyńska M; Picado C; Scadding G; Kowalski ML; Setkowicz M; Ring J; Brockow K; Bachert C; Wöhrl S; Dahlén B; Szczeklik A
    Allergy; 2007 Oct; 62(10):1111-8. PubMed ID: 17521312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Indications for the aspirin provocation test in the asthmatic].
    Michel O; Naeije N; Bracamonte M; Sergysels R; Duchateau J
    Rev Pneumol Clin; 1984; 40(6):369-71. PubMed ID: 6531573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scoring tool for systemic symptoms during aspirin challenge detects mediator production in aspirin-exacerbated respiratory disease.
    Staso PJ; Wu P; Laidlaw TM; Cahill KN
    Ann Allergy Asthma Immunol; 2021 Jul; 127(1):131-133. PubMed ID: 33781934
    [No Abstract]   [Full Text] [Related]  

  • 9. Aspirin-exacerbated respiratory disease: is it in our DNA?
    Chang J; Simon RA; Stevenson DD
    Ann Allergy Asthma Immunol; 2011 Apr; 106(4):263-4. PubMed ID: 21457872
    [No Abstract]   [Full Text] [Related]  

  • 10. [Provocation tests in the diagnosis of acetylsalicylic acid intolerance].
    Semik A; Barczyk A; Pierzchała W
    Wiad Lek; 2005; 58(9-10):543-8. PubMed ID: 16529067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin desensitization in aspirin-exacerbated respiratory disease.
    White AA; Stevenson DD
    Immunol Allergy Clin North Am; 2013 May; 33(2):211-22. PubMed ID: 23639709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Respiratory manifestations and intolerance to aspirin and non-steroidal anti-inflammatory agents].
    Grilliat JP; Moneret-Vautrin DA; You B; Reynier A
    Ann Med Interne (Paris); 1984; 135(1):21-5. PubMed ID: 6422821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational approach to aspirin dosing during oral challenges and desensitization of patients with aspirin-exacerbated respiratory disease.
    Hope AP; Woessner KA; Simon RA; Stevenson DD
    J Allergy Clin Immunol; 2009 Feb; 123(2):406-10. PubMed ID: 19056109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure to maintain an aspirin-desensitized state in a patient with aspirin-exacerbated respiratory disease.
    White AA; Hope AP; Stevenson DD
    Ann Allergy Asthma Immunol; 2006 Oct; 97(4):446-8. PubMed ID: 17069096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin and food dye reactions.
    Condemi JJ
    Bull N Y Acad Med; 1981 Sep; 57(7):600-7. PubMed ID: 6944135
    [No Abstract]   [Full Text] [Related]  

  • 16. [Differences in the course of exercise-induced bronchial spasm in pollen asthma and bronchial asthma with aspirin hypersensitivity].
    Rozniecki J; Grabski W; Kowalski ML; Grzelewska-Rzymowska I
    Pol Tyg Lek; 1981 Feb; 36(8):289-92. PubMed ID: 7267446
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hypersensitivity to aspirin and other non-steroidal anti- inflammatory agents--the methods of detecting the hypersensitivity and the development of the state of tolerance].
    Grzelewska-Rzymowska I; Rozniecki J; Szmidt M
    Pol Arch Med Wewn; 1989 Feb; 81(2):107-13. PubMed ID: 2694121
    [No Abstract]   [Full Text] [Related]  

  • 18. Recognising the risk of aspirin-sensitive respiratory disease in a patient with asthma who has previously tolerated aspirin.
    Abayaratne D; Kurukulaaratchy RJ
    Prim Care Respir J; 2011 Jun; 20(2):214-7. PubMed ID: 21311841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatitis as a novel complication of aspirin therapy in patients with aspirin-exacerbated respiratory disease.
    Hoyte FC; Weber RW; Katial RK
    J Allergy Clin Immunol; 2012 Jun; 129(6):1684-6. PubMed ID: 22236727
    [No Abstract]   [Full Text] [Related]  

  • 20. Aspirin exacerbated respiratory disease (AERD): molecular and cellular diagnostic & prognostic approaches.
    Hybar H; Saki N; Maleknia M; Moghaddasi M; Bordbar A; Naghavi M
    Mol Biol Rep; 2021 Mar; 48(3):2703-2711. PubMed ID: 33625688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.